The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation
Author(s) -
Nikolaos Charalampakis,
Graciela M. NoguerasGonzález,
Elena Elimova,
Roopma Wadhwa,
Hironori Shiozaki,
Yusuke Shimodaira,
Mariela A. Blum,
Jane E. Rogers,
Kazuto Harada,
Aurelio Matamoros,
Tara Sagebiel,
Prajnan Das,
Bruce D. Minsky,
Jeffrey H. Lee,
Brian Weston,
Manoop S. Bhutani,
Jeannelyn S. Estrella,
Brian D. Badgwell,
Jaffer A. Ajani
Publication year - 2016
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000443506
Subject(s) - medicine , gastroenterology , signet ring cell , adenocarcinoma , histology , chemotherapy , stage (stratigraphy) , proto oncogene tyrosine protein kinase src , cancer , biology , receptor , paleontology
Patients with localized gastric adenocarcinoma (LGAC), who get pre-operative therapy, have heterogeneous/unpredictable outcomes. Predictive clinical variables/biomarkers are not established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom